Cargando…
Bladder Paraganglioma: Three Cases Report and Literature Review
BACKGROUND: Bladder paraganglioma (BPG) is one of the rare neuroendocrine neoplasms that develops from neural crest cells. It categorizes into functional and non-functional types based on the catecholamines secretion. Currently, functional BPG is predicted in advance based on signs and symptoms of c...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594893/ https://www.ncbi.nlm.nih.gov/pubmed/34803407 http://dx.doi.org/10.2147/IMCRJ.S336659 |
_version_ | 1784600079959588864 |
---|---|
author | Yuan, Yaoji Su, Zhengming Zhu, Rui Li, Xiezhao Xu, Guibin |
author_facet | Yuan, Yaoji Su, Zhengming Zhu, Rui Li, Xiezhao Xu, Guibin |
author_sort | Yuan, Yaoji |
collection | PubMed |
description | BACKGROUND: Bladder paraganglioma (BPG) is one of the rare neuroendocrine neoplasms that develops from neural crest cells. It categorizes into functional and non-functional types based on the catecholamines secretion. Currently, functional BPG is predicted in advance based on signs and symptoms of catecholamine excess, such as hypertension and “micturition attacks”. However, it is often overlooked because of its rareness. Misdiagnosis of a functional tumor may increase the risk of surgical intervention. CASE PRESENTATION: We reported 3 cases of BPG that they were admitted to the hospital due to abdominal pain or gross hematuria. Computed tomography (CT) scans showed space-occupying lesions in the bladders with diameters less than 3cm. There were no typical catecholamine excess symptoms before surgical intervention. Postoperative pathology confirmed BPG after removal of the tumor. We also analyze 69 cases of BPG that has been reported and found that 78.0% cases were functional among the tumors larger than 3cm. CONCLUSION: Bladder tumors larger than 3cm in diameter can serve as an additional predictor of functional BPG. Patients who are suspected should undergo magnetic resonance imaging (MRI) scans, 123/131 metaiodobenzylguanidine (MIBG) scan, and have their catecholamine levels tested. Once the diagnosis is confirmed, patients should be started on fluid replacement therapy and adrenergic blockade to abate the disorders associated with catecholamine excess. |
format | Online Article Text |
id | pubmed-8594893 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-85948932021-11-18 Bladder Paraganglioma: Three Cases Report and Literature Review Yuan, Yaoji Su, Zhengming Zhu, Rui Li, Xiezhao Xu, Guibin Int Med Case Rep J Case Series BACKGROUND: Bladder paraganglioma (BPG) is one of the rare neuroendocrine neoplasms that develops from neural crest cells. It categorizes into functional and non-functional types based on the catecholamines secretion. Currently, functional BPG is predicted in advance based on signs and symptoms of catecholamine excess, such as hypertension and “micturition attacks”. However, it is often overlooked because of its rareness. Misdiagnosis of a functional tumor may increase the risk of surgical intervention. CASE PRESENTATION: We reported 3 cases of BPG that they were admitted to the hospital due to abdominal pain or gross hematuria. Computed tomography (CT) scans showed space-occupying lesions in the bladders with diameters less than 3cm. There were no typical catecholamine excess symptoms before surgical intervention. Postoperative pathology confirmed BPG after removal of the tumor. We also analyze 69 cases of BPG that has been reported and found that 78.0% cases were functional among the tumors larger than 3cm. CONCLUSION: Bladder tumors larger than 3cm in diameter can serve as an additional predictor of functional BPG. Patients who are suspected should undergo magnetic resonance imaging (MRI) scans, 123/131 metaiodobenzylguanidine (MIBG) scan, and have their catecholamine levels tested. Once the diagnosis is confirmed, patients should be started on fluid replacement therapy and adrenergic blockade to abate the disorders associated with catecholamine excess. Dove 2021-11-12 /pmc/articles/PMC8594893/ /pubmed/34803407 http://dx.doi.org/10.2147/IMCRJ.S336659 Text en © 2021 Yuan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Case Series Yuan, Yaoji Su, Zhengming Zhu, Rui Li, Xiezhao Xu, Guibin Bladder Paraganglioma: Three Cases Report and Literature Review |
title | Bladder Paraganglioma: Three Cases Report and Literature Review |
title_full | Bladder Paraganglioma: Three Cases Report and Literature Review |
title_fullStr | Bladder Paraganglioma: Three Cases Report and Literature Review |
title_full_unstemmed | Bladder Paraganglioma: Three Cases Report and Literature Review |
title_short | Bladder Paraganglioma: Three Cases Report and Literature Review |
title_sort | bladder paraganglioma: three cases report and literature review |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594893/ https://www.ncbi.nlm.nih.gov/pubmed/34803407 http://dx.doi.org/10.2147/IMCRJ.S336659 |
work_keys_str_mv | AT yuanyaoji bladderparagangliomathreecasesreportandliteraturereview AT suzhengming bladderparagangliomathreecasesreportandliteraturereview AT zhurui bladderparagangliomathreecasesreportandliteraturereview AT lixiezhao bladderparagangliomathreecasesreportandliteraturereview AT xuguibin bladderparagangliomathreecasesreportandliteraturereview |